Boston, MA, United States of America

Adam Szymaniak

This inventor holds 11 USPTO granted patents and 4 published patent applications. Top assignee: Enanta Pharmaceuticals, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Szymaniak. Retrieved from https://idiyas.com/inventor/adam-szymaniak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 100.0

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Inventor Adam Szymaniak: Pioneering Innovations in Boston

Introduction: Adam Szymaniak is a visionary inventor based in Boston, Massachusetts, known for his groundbreaking contributions to various technological fields.

Latest Patents: Adam Szymaniak holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Adam Szymaniak has successfully brought numerous inventions from concept to reality, revolutionizing industries along the way.

Collaborations: Throughout his career, Adam Szymaniak has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, solidifying his reputation as a forward-thinking inventor.

Conclusion: Adam Szymaniak's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a prominent figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…